Powered by HealthTechMovers.com
We added 2 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Bicycle Therapeutics, BCYC
Summary: Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.
- Last Price: 50.66
- Price Change: -0.11, -0.22%
- Yearly Gain: 155.77%
- Market Cap: 1.49B
- P/E Ratio: -17.525
Here are 3rd party ratings for BCYC:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Bottom 35% (165 out of 254)
What is the sentiment on the street regarding Bicycle Therapeutics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: Medium
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: No Signal
If you are interested in BCYC or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on BCYC before you decide to make any investment.
Click here for chart >>
Sight Sciences, SGHT
Summary: Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.
- Last Price: 16.75
- Price Change: -0.47, -2.73%
- Yearly Gain: -48.60%
- Market Cap: 792.40M
- P/E Ratio: -14.445
Here are 3rd party ratings for SGHT:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: n/a
- Barchart.com: n/a
- Zacks.com: Buy, Bottom 33% (169 out of 254)
What is the sentiment on the street regarding Sight Sciences ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: Medium
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: Neutral
If you are interested in SGHT or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on SGHT before you decide to make any investment.
Click here for chart >>
Thanks for reading!
